BIS News and Press, ProShares UltraShort Nasdaq Biotechnology From 05/06/22

A phase 2a study using Lomecel-B for Alzheimer's Disease is currently enrolling patients; a prior phase 1 study established excellent safety profile with some efficacy. The global Alzheimer's Disease market could reach $25 billion by 2027. Lomecel-B has several shots on goal; besi...

FBT doesn’t pay any dividend and had a negative price growth over the short term. Barring the inverse funds, all other biotechnology ETFs had a high negative growth over the past 12 months. FBT’s price multiples are around category average, and current price is quite...

KPTI has been devastated by the SIENDO trial failure. The next trial's data will be read out 2 years later. Until then, I see little upside for the stock. For further details see: Karyopharm: Another 2 Year Wait For Data

MorphoSys stock has taken a huge hit since its Constellation buyout. The company has staked an entire existing revenue stream for a development stage asset. The market hasn't taken this kindly. For further details see: MorphoSys May Not Recover From Adventurous Constella...

Price pressures are most concentrated in those sectors reporting the greatest constraints. Output consequently fell in China as well as a number of other smaller Asia-Pacific economies, and growth slowed in the US and Europe. The constraints on production caused by a lack of input...

Defensive stocks are often misunderstood. In recent years, even when they have delivered strong and steady earnings, returns have disappointed. After a period of underperformance for defensives, a broadening market can represent real opportunity. Beyond utilities, we believe that ...

Much of last week’s economic focus was on the inflation report. Inflation was indeed pretty hot year over year, but that wasn’t unexpected. With CPI printing at 5% year over year, bond yields fell. But these are small moves, and the trend for rates is still up for now. ...

Gainers: S&P Biotech Bull 3X Direxion (LABU) +21.7%.Breakwave Dry Bulk Shipping ETF (BDRY) +18.4%.Pharmaceutical & Medical Bull 3X Direxion (PILL) +14.5%.Ultra Nasdaq Biotech Proshares (BIB) +11.8%.Ultra DJ-UBS Natural Gas Proshares (BOIL) +11.6%.Losers: ...

From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...

Historic efforts to develop COVID-19 vaccines have had two huge effects on the industry. Efforts to waive patents on COVID-19 vaccines to help reduce costs for emerging markets are also stuck. Since healthcare is an industry that has a profound impact on society, there’s a ...